Ulwazi olwengeziwe ― Zulu

Confluent and reticulated papillomatosis (CRP) , ebizwa nangokuthi i-Gougerot-Carteaud syndrome, iphumela ekukhuleni kwamangqamuzana esikhumba okungavamile. Ibonakala njengamachashaza amnyama angenabuhlungu angahlangana abe neziqephu ezinkulu, ngokuvamile avele phezulu esifubeni nasentanyeni yentsha kanye nabantu abadala. Ukukhethwa kokuqala kokwelashwa yi-minocycline.
Confluent and reticulated papillomatosis (CRP), also known as Gougerot-Carteaud syndrome, is caused by disordered keratinization. It presents with asymptomatic hyperpigmented papules that can coalesce into plaques and are typically located on the upper trunk and neck of teens and young adults. First-line treatment is oral 'minocycline'.

I-CRP ivamise ukuvela njengamachashaza amnyama nama-patches ngaphandle kwezimpawu esikhumbeni esizungeze intamo, amakhwapha, isifuba esingenhla, nangaphezulu. Kwesinye isikhathi, ingasakazeka iye esiphongweni futhi yehle endaweni ye-pubic. Imithi elwa namagciwane efana ne- minocycline isiyinketho yokwelashwa ekhethwayo.
CRP typically presents as asymptomatic hyperpigmented papules and plaques with peripheral reticulation over the nape, axillae, upper chest, and upper back, occasionally with extension superior to the forehead and inferior to the pubic region. Antibiotics, such as 'minocycline', at anti-inflammatory doses have emerged as a preferred therapeutic option.